BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34708579)

  • 1. Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.
    Ho PJ; Wong FY; Chay WY; Lim EH; Lim ZL; Chia KS; Hartman M; Li J
    Cancer Med; 2021 Nov; 10(22):8182-8191. PubMed ID: 34708579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.
    Chay WY; Ong WS; Tan PH; Jie Leo NQ; Ho GH; Wong CS; Chia KS; Chow KY; Tan M; Ang P
    Breast Cancer Res; 2012 Jan; 14(1):R19. PubMed ID: 22289271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
    Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
    Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.
    Olson JE; Sellers TA; Scott CG; Schueler BA; Brandt KR; Serie DJ; Jensen MR; Wu FF; Morton MJ; Heine JJ; Couch FJ; Pankratz VS; Vachon CM
    Breast Cancer Res; 2012 Nov; 14(6):R147. PubMed ID: 23152984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction.
    Lee CP; Choi H; Soo KC; Tan MH; Chay WY; Chia KS; Liu J; Li J; Hartman M
    PLoS One; 2015; 10(9):e0136650. PubMed ID: 26401662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with false-positive mammography at first screen in an Asian population.
    Ho PJ; Bok CM; Ishak HMM; Lim LY; Liu J; Wong FY; Chia KS; Tan MH; Chay WY; Hartman M; Li J
    PLoS One; 2019; 14(3):e0213615. PubMed ID: 30856210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
    Wang WV; Tan SM; Chow WL
    Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
    Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
    JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
    Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
    Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography.
    Keller BM; Chen J; Daye D; Conant EF; Kontos D
    Breast Cancer Res; 2015 Aug; 17():117. PubMed ID: 26303303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
    Tice JA; Cummings SR; Ziv E; Kerlikowske K
    Breast Cancer Res Treat; 2005 Nov; 94(2):115-22. PubMed ID: 16261410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Incidence After a False-Positive Mammography Result.
    Mao X; He W; Humphreys K; Eriksson M; Holowko N; Yang H; Tapia J; Hall P; Czene K
    JAMA Oncol; 2024 Jan; 10(1):63-70. PubMed ID: 37917078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
    Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
    Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
    Moshina N; Backmann HA; Skaane P; Hofvind S
    Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.